These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition. Rowe JB; Hughes L; Ghosh BC; Eckstein D; Williams-Gray CH; Fallon S; Barker RA; Owen AM Brain; 2008 Aug; 131(Pt 8):2094-105. PubMed ID: 18577547 [TBL] [Abstract][Full Text] [Related]
8. Researching a differential impairment of frontal functions and explicit memory in early Parkinson's disease. Farina E; Gattellaro G; Pomati S; Magni E; Perretti A; Cannatà AP; Nichelli P; Mariani C Eur J Neurol; 2000 May; 7(3):259-67. PubMed ID: 10886309 [TBL] [Abstract][Full Text] [Related]
9. Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: the role of rule reconfiguration. Kehagia AA; Barker RA; Robbins TW J Neuropsychol; 2014 Mar; 8(1):53-74. PubMed ID: 23279799 [TBL] [Abstract][Full Text] [Related]
10. Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuits. Gruszka A; Hampshire A; Barker RA; Owen AM Cortex; 2017 Aug; 93():178-192. PubMed ID: 28667892 [TBL] [Abstract][Full Text] [Related]
11. Progression of regional cortical cholinergic denervation in Parkinson's disease. Bohnen NI; Roytman S; Kanel P; Müller MLTM; Scott PJH; Frey KA; Albin RL; Koeppe RA Brain Commun; 2022; 4(6):fcac320. PubMed ID: 36569603 [TBL] [Abstract][Full Text] [Related]
12. Distinct contributions of lateral orbito-frontal cortex, striatum, and fronto-parietal network regions for rule encoding and control of memory-based implementation during instructed reversal learning. Ruge H; Wolfensteller U Neuroimage; 2016 Jan; 125():1-12. PubMed ID: 26471057 [TBL] [Abstract][Full Text] [Related]
13. Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson's disease. Rolinski M; Zokaei N; Baig F; Giehl K; Quinnell T; Zaiwalla Z; Mackay CE; Husain M; Hu MT Brain; 2016 Jan; 139(Pt 1):47-53. PubMed ID: 26582557 [TBL] [Abstract][Full Text] [Related]
14. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study. Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470 [TBL] [Abstract][Full Text] [Related]
15. The pattern of attentional deficits in Parkinson's disease. Dujardin K; Tard C; Duhamel A; Delval A; Moreau C; Devos D; Defebvre L Parkinsonism Relat Disord; 2013 Mar; 19(3):300-5. PubMed ID: 23196037 [TBL] [Abstract][Full Text] [Related]
16. Memory deficits in Parkinson's disease are associated with reduced beta power modulation. MacDonald HJ; Brittain JS; Spitzer B; Hanslmayr S; Jenkinson N Brain Commun; 2019; 1(1):fcz040. PubMed ID: 32090200 [TBL] [Abstract][Full Text] [Related]
17. Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease. Lewis SJ; Cools R; Robbins TW; Dove A; Barker RA; Owen AM Neuropsychologia; 2003; 41(6):645-54. PubMed ID: 12591022 [TBL] [Abstract][Full Text] [Related]
18. Corticostriatal beta oscillation changes associated with cognitive function in Parkinson's disease. Paulo DL; Qian H; Subramanian D; Johnson GW; Zhao Z; Hett K; Kang H; Chris Kao C; Roy N; Summers JE; Claassen DO; Dhima K; Bick SK Brain; 2023 Sep; 146(9):3662-3675. PubMed ID: 37327379 [TBL] [Abstract][Full Text] [Related]